Finished Dosage Forms and Raw Materials for the Pharmaceutical and Food Industries.
We are a multinational Brazilian company, incorporated in 1984, working in manufacturing raw materials and finished dosage formulations.
Regarding raw materials, we work on manufacturing pharmaceutical excipients, active pharmaceutical ingredients (APIs) and food ingredients, supplying to the pharmaceutical, nutraceutical, food, veterinary, and other industries. Recognized by the high quality and global technical support, we currently trade our products in over 100 countries in all continents.
Concerning finished dosage formulations, we work within the HIV, Hepatitis, Osteoporosis, and other segments of therapies. Initially focused on the local market, right now our strategy consists of expanding internationally. To reach this objective we count on a highly qualified structure to meet the strictest worldwide regulatory criteria.
We own three production plants in Brazil, with offices in the United States and Europe.
Blanver understands the needs of its customers, consumers and the market, to then propose efficient, distinctive and distinguished solutions with unique quality.
To develop, manufacture and market innovative products with quality and competitiveness for people’s health and wellbeing.
To be among the 500 largest companies in Brazil, meeting shareholders’ profitability expectations.
- Respect for People
- Respect for Rules
- Result Oriented
- Quality Oriented
- Social Responsibility